CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,081 Cr | ₹951 Cr | ₹754 Cr | ₹536 Cr | ₹288 Cr |
What is the latest Net Current Assets ratio of CONCORD BIOTECH ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,081 Cr |
| Mar2025 | ₹951 Cr |
| Mar2024 | ₹754 Cr |
| Mar2023 | ₹536 Cr |
| Mar2022 | ₹288 Cr |
How is Net Current Assets of CONCORD BIOTECH Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,081 Cr | 13.65 | |
| Mar2025 | ₹951 Cr | 26.14 | |
| Mar2024 | ₹754 Cr | 40.72 | |
| Mar2023 | ₹536 Cr | 85.79 | |
| Mar2022 | ₹288 Cr | - | |
Compare Net Current Assets of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,640.9 Cr | 1.9% | 2.6% | -28.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 1.9% |
2.6% |
-28.3% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses